The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by Yash Verma, 2019-12-24 01:05:58

Pinnacle Dec Issue

www.alniche.com

QUARTERLY HIGHLIGHTS Alniche Pinnacle, Issue - II | 2019-20

• New Office Highlights
• Diwali Celebration In Office
• New Launches
• Recognition Of Performers at DPSRU
• Scaling New Heights
• Recognition By JW Holdings Korea
• Publication, Awards & Accolades
• Conference Participation 2019

From MD's Desk

Dear Colleagues,

The Indian pharmaceutical industry is poised for growth. Even at
current rate of seven to eight percent CAGR, the industry's
annual revenues can grow to about USD 80 to 90 billion by 2030.
However, it could also set bold aspirations of eleven to twelve
percent CAGR, and grow to annual revenues of about ~USD 65
billion by 2024 and about ~USD 120 to 130 billion by 2030.

Our organization is one of the fastest growing super specialty
pharmaceutical company in India. Today, we formally stand one
among the top companies in Nephrology, amongst top 10
companies in Critical Care, well established in Skinceuticals,
Gastroenterology and Advanced Wound care in PAN India. To
expand our product portfolio, we launched Neuro –Psychiatry
division to ensure patients well-being.

Our efforts are globally recognized like Super 30 Companies award by Silicon Review New Jersey, USA,
Companies of the year award by Business Connect India and also we are recognized as Noteworthy Biotech
and Pharma Companies by Business APAC.

It is a matter of great pride for all of us that Alniche was recently bestowed with Excellence in Pharmaceutical
Brand Management – New Product Launch award by CPhI- India Pharma awards 2019.

CPhI (Informa markets) is a Netherlands based global organization that evaluates the concept and performance
of new products and recognizes the best among them with an award and certificate of appreciation.

This noteworthy performance of our organization has been possible only through the hard work and dedicated
commitment of each and every employee of the organization. I must acknowledge the hard work of team at
head office who has been supporting our sales team in ensuring to meet the organization objective of being
among top 50 pharma companies by year 2020.

I have tremendous confidence in entire Alniche team and I am sure all of us together will achieve the
common goal of “GROWTH & PROSPERITY”. I would like to end my message by quoting Dr. A.P.J. Abdul
Kalam,“I will do it, We will do it, Alniche team will do it.”

With best wishes to you and your family and a Happy New Year to all!

Girish Arora
Founder & Managing Director

NEW OFFICE HIGHLIGHTS

New Delhi, India

After ten years of success, we have renovated our office to a new and bigger space. A small
puja and opening ceremony was conducted in the morning hours and celebration took place in
order to make this occasion even more memorable.

It started with the ribbon cutting ceremony by our Founder & MD, Mr. Girish Arora and lightning of auspicious
diya ceremony in the flower-decorated reception area. The new beautiful space will allow the team to grow
leaps and bounds in the coming years. Work commences from a new office. We all, start afresh, with a lot of
new hopes, aspirations, aims and goals.

DIWALI CELEBRATION IN OFFICE

Festive Flavour

Dazzling earthen lamps, vivid lights and mesmerizing
rangolis are the real gems in Diwali celebration. Diwali
celebrations in office traditionally involved Laxmi puja
followed by distribution of gifts and prasad.

On the Diwali Pooja day, everyone was looking traditional with a twist of ethnic attire. Diwali fills the air with
positivity and prepares everyone to welcome the next year with optimism.

NEW LAUNCH

Neuro-Psychiatry division Launch

To expand our product portfolio, we entered into Neuro-psychiatry division to ensure patient’s well-being.

Key Products

New Product

• Combiklas 384 ml - 1st innovative TPN (total parenteral nutrition).
• TPN is IV nutrition solution for patients in case of non-functional

GI tract.
• Combiklas is an integral part of treatment to fulfill nutritional

requirements in ICU patients.
• Combiklas contains specialized nutrients such as amino acids,

fat emulsion, protein, vitamins, minerals & trace elements along
with dextrose.

RECOGNITION OF PERFORMERS

At DPSRU (Delhi Pharmaceutical Science and Research University)

Standing Right to Left : Prof. ( Dr. ) Harvinder Popli ( Professor pharmaceutics DPSRU), Dr. Ramesh K. Goyal ( Vice-Chancellor DPSRU), Mr. Karan Arora (Director International Business Alniche Lifesciences),
Mr. Vijay Chauhan ( Head-BD Alniche Lifesciences) & Dr. Geeta Aggarwal (Assistant Registrar DPSRU)

To encourage academic performance and empower development of innovative healthcare products
Alniche bestowed two trophies to DPSRU namely Vijayin Alniche Trophy and Jwalat Alniche trophy

Presenting JWALAT- ALNICHE AWARD Presenting VIJAYIN- ALNICHE AWARD

SCALING NEW HEIGHTS

CPhI- India pharma Award 2019

Alniche won New Product Launch Award for Complipro under the category of Excellence in Pharmaceutical
Brand Management. In this category, another brand Ketoalfa was among top brands nominated.

The company had to go through a two phased screening process (a) Pre-qualification based on stringent
criteria (b) evaluation by the Jury of eminent persons.
The selection criteria included - New Product Development and Quality Management,
Unique features that filled the need gap in the concerned segment, Initiatives pertaining
to gathering consumer insights, Customer Satisfaction Measurement, Customer Value
Management, Operational Management, Initiatives that contributed to the growth of the
brand/product.
In the second phase, interaction with a distinguished panel of eminent jury, unanimously
decided this Award based on the presentation of our product.

“The Winning of this prestigious Award
shall usher Alniche in a new era of
growth by instilling faith and image
amongst our valued customers”

RECOGNITION BY JW HOLDINGS KOREA

JW Holdings Global Partners Day 2019

Alniche has been appreciated for increasing the brand value of COMBIKLAS in India by JW Holdings president
Mr. Sung- Kwon Han.

Our directors were honored at JW headquarters Korea during JW Global Partners day 2019.
This day comprised of brand presentations by multiple partners, discussions and experience sharing about
marketing of JW products and also visit to factory to witness the state of art manufacturing facility.

PUBLICATIONS

Business Narratives

Patient Awareness Articles

Awards and Accolades Recognized in Noteworthy
Biotech & Pharma Company
Appreciated as the
Companies of the by Business APAC

year 2019 by
Business Connect

CONFERENCE PARTICIPATION 2019

Major Participation

Alniche has always moved hand in hand with doctors to provide them continuing medical education and
keeping them updated by participating in various speciality CMEs. Major being:

ISNCON 2019 ISGCON MPCG Chapter2019 EZCC Con 2019 LET'S – CiDAAP 2019

International Critical Care CAST 2019 6th KMC GASTROCON 2019 ISCCM Chapter Gujarat 2019
Update Conference 2019

Our Leadership Team

Mr. Jayan C.P Mr. Mumtaz Siddique Mr. Pravin Naik Mr. Bishwa Sahoo Mr. Praveen Gautam

Let us do something incredible
This New Year to expand our horizon

WISHhYaOUpApSyUCCnESeSwFUL yANeDaGLrORIOUS


Click to View FlipBook Version